Yorke Justin W — SEC Form 4 filings
SEC reporting owner CIK 1361896. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-28.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-31 to 2026-07-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 20,400 shares, $31,433 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: purchase of 8,000 shares @ $2.69 ($21,544) in Processa Pharmaceuticals, Inc., filed 2024-01-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | Director | 9 | 2 legs · 20,400 sh · $31,433 | — | 9 |
| SPLASH BEVERAGE GROUP, INC. (SBEV) | Director | 1 | — | — | 1 |
Form 4 filings — Yorke Justin W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-28 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 33,500 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Option exercise (M): 203 · Option exercise (M): 203 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | SPLASH BEVERAGE GROUP, INC. (SBEV) | Grant/award (A): 750,000 (derivative) | EDGAR |
| 2025-10-03 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-09-18 | 4/A | Processa Pharmaceuticals, Inc. (PCSA) | Holdings only — no transactions reported | EDGAR |
| 2025-07-28 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 175,299 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4/A | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 12,400 (derivative) @ $0 · Grant/award (A): 6,200 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 12,400 @ $0.80 | EDGAR |
| 2024-09-18 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 31,206 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 8,000 @ $2.69 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1361896 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →